NCT00032669View on ClinicalTrials.gov

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

April 30, 2006

Conditions
HIV Infections
Interventions
DRUG

HAART

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00032669 - Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children | Biotech Hunter | Biotech Hunter